Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

BK virus and immunosuppressive agents.

Irfan Agha1, Daniel C Brennan

  • 1St Louis University School of Medicine, St Louis VA Medical Center, Missouri, USA.

Advances in Experimental Medicine and Biology
|April 22, 2006
PubMed
Summary

BK virus (BKV) infection is a significant cause of kidney transplant loss due to potent immunosuppressive drugs. Understanding host factors and immunosuppression is key for early diagnosis and management of BKV-associated nephropathy (BKVN).

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Elevations in Donor-Derived Cell-Free DNA and Allograft Outcomes in Kidney Transplantation.

Journal of the American Society of Nephrology : JASN·2026
Same author

Assessment of colorectal cancer recurrence risk following solid organ transplantation.

Journal of gastrointestinal oncology·2026
Same author

The Association Between Post-Kidney Transplant Persistent Hyperparathyroidism and Fracture Risk: A Longitudinal Cohort Study.

Clinical transplantation·2026
Same author

Institutional Strategies for Overcoming Academic Bullying, Rising Above Moral Injury, and Achieving Success.

Transplantation·2026
Same author

Burden of adverse transplant outcomes in kidney transplant recipients with COVID-19 and invasive fungal infections: a retrospective cohort study.

BMC infectious diseases·2026
Same author

"You Gotta Keep Climbing That Mountain to Reach the Goal": Perspectives of Transplant Waitlisted Dialysis Patients. A Qualitative Study.

Kidney medicine·2026

Area of Science:

  • Transplant Medicine
  • Virology
  • Nephrology

Background:

  • Potent immunosuppressive agents have increased BK virus (BKV) complications in kidney transplant recipients.
  • BKV infection can lead to significant allograft loss, with BKV-associated nephropathy (BKVN) affecting approximately 5% of patients.
  • While BKV is latent in most healthy adults, immunocompromised individuals are at high risk for reactivation and disease.

Purpose of the Study:

  • To discuss the clinical aspects of BKV infection in renal transplant recipients.
  • To examine the role of immunosuppression in BKV replication and the pathogenesis of BKVN.
  • To identify host factors that may act as a 'second hit' in the development of BKVN.

Main Methods:

  • Review of clinical aspects of BKV infection in renal transplant recipients.
  • Focus on the impact of immunosuppressive regimens (e.g., tacrolimus, mycophenolate mofetil) on BKV replication.
  • Discussion of host factors contributing to BKVN development.
  • Presentation of results from a prospective study on immunosuppressive agents and BKVN.

Main Results:

  • Immunosuppression is a critical factor enabling BKV replication.
  • Not all patients with replicating BKV develop nephropathy, indicating the involvement of additional host factors.
  • Results from a prospective study on immunosuppressive agents and BKVN development will be presented.

Conclusions:

  • Reactivation of latent BKV depends on immunosuppression, but other factors are crucial for clinical disease.
  • Early diagnosis and management strategies for BKVN are essential to prevent allograft loss.
  • Guidelines for managing BKVN based on clinical experience will be provided.

Related Experiment Videos